![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Vascepa gains event-reduction nod; diabetes ups ischemic risks (MDedge: news and insights for busy physicians) View |
![]() |
Robert Busch, MD: REDUCE-IT Trial Implications, Icosapent Ethyl for Diabetes Patients (HCPLive) View |
![]() |
021 - Amarin's Vascepa Success (Breaking Biotech) View |
![]() |
Vascepa - Icosapent (Riverside Rx Services) View |
![]() |
Episode 14 - Vascepa, Vyondys 53, u0026 Padcev (The Rx Daily Dose (The Rx Daily Dose)) View |
![]() |
Vascepa cuts CVD as proved by Reduce-It trial and Evaporate trial by Dr. Maged Taman (Maged Taman) View |
![]() |
New FDA Approval of Medication to Reduce Cardiovascular Health Risks (FCL Jan. 8) (First Coast News) View |
![]() |
Amarin Vascepa vs Hikma Generic: Review Part 1 with SMELL test (Mike Decker) (Mike Decker - High Road Living) View |
![]() |
Day 15 - Amarin Vascepa vs Hikma Generic: Review Part 2 (Mike Decker - High Road Living) View |
![]() |
() View |